New patient pricingon weight loss plans, starting at $99/mo

Understanding BMI and GLP-1 Eligibility

LM

Written by Luma Team

August 16, 2026 · 11 min read

Woman stepping onto a bathroom scale at home while tracking her weight-management progress

If you're considering a GLP-1 medication for weight loss, one of the first numbers you may encounter is your BMI.

BMI is commonly used when healthcare providers evaluate whether someone may be eligible for prescription weight-management medications such as semaglutide or tirzepatide.

But BMI isn't the entire story.

Your medical history, current health conditions, medications, previous weight-loss efforts, and overall treatment goals can also be important.

Here's what BMI means and how it fits into GLP-1 eligibility.

What Is BMI?

BMI stands for Body Mass Index.

It's a calculation that compares your weight with your height.

The formula is:

  • Metric: BMI = weight in kilograms ÷ height in meters²
  • Pounds and inches: BMI = weight in pounds ÷ height in inches² × 703

You don't usually need to calculate this yourself, because BMI calculators can determine it from your height and weight.

For adults, BMI is generally categorized as:

Standard adult BMI categories
BMICategory
Below 18.5Underweight
18.5 – 24.9Healthy weight
25.0 – 29.9Overweight
30.0 – 34.9Class 1 obesity
35.0 – 39.9Class 2 obesity
40.0+Class 3 obesity

BMI is widely used because it's quick, inexpensive, and easy to calculate.

What BMI Qualifies for GLP-1 Weight Loss Treatment?

For adults, commonly used eligibility criteria for prescription medications approved for chronic weight management include:

  • BMI of 30 or greater, or
  • BMI of 27 or greater with at least one weight-related health condition.

That means someone doesn't necessarily need to have a BMI above 30 to potentially qualify.

For example, an adult with a BMI of 28 may meet the weight-related criteria if they also have an appropriate health condition associated with excess weight.

Eligibility is not automatic

Eligibility is not automatic

Final eligibility still depends on the specific medication and an evaluation by a licensed healthcare provider.

Can You Qualify With a BMI Between 27 and 29.9?

Potentially, yes.

This is one of the most common areas of confusion.

A BMI between 25 and 29.9 falls within the overweight category.

For many chronic weight-management medications, someone with a BMI of at least 27 plus a qualifying weight-related condition may meet the weight-related criteria for treatment.

  • BMI 28 + hypertension — may meet the weight-related eligibility criteria.
  • BMI 28 without a weight-related condition — may not meet the labeled weight criteria for certain medications used specifically for chronic weight management.

A healthcare provider still needs to evaluate the complete situation.

What If Your BMI Is 30 or Higher?

A BMI of 30 or greater falls within the obesity category for adults.

For medications with the common chronic weight-management criteria described above, a BMI of 30 or greater can meet the weight-related threshold without requiring an additional weight-related condition.

However:

  • Meeting the BMI threshold doesn't automatically mean a medication is appropriate for you.
  • BMI is only one part of the medical evaluation.

A provider still needs to consider your health history, current medications, potential contraindications, treatment goals, and other relevant factors.

How Do You Calculate Your BMI?

Here's a simple example.

Imagine someone is 5'5" and 180 pounds.

Their BMI would be approximately 30.0, which places them around the threshold for the obesity category.

Another person could weigh exactly 180 pounds but be considerably taller, giving them a lower BMI.

That's why weight alone isn't generally used to determine weight category. Height matters too.

Does BMI Measure Body Fat?

Not directly.

BMI estimates weight relative to height.

It doesn't actually measure how much of someone's body is:

  • Fat
  • Muscle
  • Bone
  • Water

It also doesn't show where body fat is located.

For example, someone with substantial muscle mass may have a relatively high BMI even though they don't have a high percentage of body fat. On the other hand, someone can have a BMI within the healthy-weight range while still having metabolic risk factors that deserve attention.

BMI is therefore best viewed as a screening tool rather than a complete measurement of someone's health.

Why Do Healthcare Providers Still Use BMI?

Despite its limitations, BMI remains useful. It's:

  • Quick
  • Standardized
  • Noninvasive
  • Easy to calculate
  • Widely studied
  • Associated with health risks at the population level

It gives healthcare providers a convenient starting point when evaluating weight-related health. But a thoughtful medical evaluation shouldn't stop at BMI.

What Else Matters Besides BMI?

A healthcare provider may consider several additional factors before prescribing a GLP-1 medication.

  • Medical history — certain conditions may affect whether a particular medication is appropriate.
  • Current medications — providers need to know what prescription medications, over-the-counter products, and supplements you're taking.
  • Weight-related conditions — hypertension, abnormal cholesterol levels, diabetes, sleep apnea, and cardiovascular disease may affect treatment decisions.
  • Previous weight-loss attempts — nutrition programs, exercise efforts, medications, or other approaches you've tried.
  • Current symptoms — digestive symptoms and other health concerns can be relevant when choosing a treatment.
  • Treatment goals — someone trying to improve several obesity-related health risks may have different considerations than someone primarily interested in losing a relatively small amount of weight.

Does a Higher BMI Mean You Need a Higher GLP-1 Dose?

Not necessarily.

GLP-1 medications generally aren't dosed simply according to someone's body weight or BMI. Someone with a BMI of 40 doesn't automatically need twice as much medication as someone with a BMI of 30.

Medications such as semaglutide and tirzepatide typically follow established dose-escalation schedules. Patients usually begin at a lower dose and gradually increase based on the medication's dosing schedule, treatment response, tolerability, and provider guidance.

The goal of titration

The goal of titration

It isn't to reach the highest dose as quickly as possible. It's to find an effective and tolerable treatment approach.

What If Your BMI Drops Below 30 While Taking a GLP-1?

This is another common question.

Imagine someone begins treatment with a BMI of 34 and eventually reaches a BMI of 27. That doesn't automatically mean the medication suddenly has to be stopped.

The patient's starting condition, treatment response, current health, and long-term weight-management plan all matter. Obesity is generally managed as a chronic condition, and maintaining lost weight can be an important part of treatment.

Research has also shown that stopping GLP-1 treatment can be followed by weight regain in some patients.

Whether treatment should continue, change, or stop should be determined with the prescribing healthcare provider rather than based on crossing a single BMI number.

What If Your BMI Is Below 27?

For the commonly used adult chronic weight-management criteria, a BMI below 27 generally falls below the labeled BMI threshold for medications such as Wegovy or Zepbound when used for weight management.

That doesn't mean BMI alone tells you whether you're healthy. It means the medication may not be indicated for weight management based on those standard BMI criteria.

Someone concerned about their weight, body composition, or metabolic health can still discuss those concerns with a healthcare provider.

Is BMI the Best Measure of Health?

No single number is.

BMI has real limitations. It doesn't distinguish muscle from fat, doesn't measure fat distribution, and doesn't directly evaluate metabolic health.

Healthcare providers may get a more complete picture by considering information such as:

  • Blood pressure
  • Waist circumference
  • Blood glucose
  • Cholesterol and triglycerides
  • Medical history
  • Family history
  • Physical activity
  • Nutrition
  • Sleep
  • Body composition when relevant

BMI can be useful without being treated as a complete definition of someone's health.

Why Does GLP-1 Eligibility Require a Medical Evaluation?

GLP-1 medications are prescription treatments.

Determining whether someone may benefit involves more than entering height and weight into a calculator. A healthcare provider needs to determine whether the treatment is medically appropriate and whether there are reasons a particular medication shouldn't be used.

The evaluation also gives patients an opportunity to discuss:

  • Treatment expectations
  • Medication options
  • Dosing
  • Side effects
  • Current medications
  • Medical conditions
  • Long-term weight-management goals

The BMI calculation is simply one part of that process.

The Bottom Line

BMI is one of the main screening tools used to determine potential eligibility for prescription weight-management medications.

For many adult GLP-1-based weight-management treatments, the commonly used weight criteria are:

  • BMI of 30 or greater, or
  • BMI of 27 or greater with at least one weight-related health condition.

But qualifying based on BMI doesn't automatically mean a medication is right for you. And BMI itself isn't a perfect measurement of health or body fat.

The best approach is to consider BMI alongside medical history, weight-related conditions, medications, treatment goals, and other measures of health.

At Luma, eligible patients complete an online medical evaluation that is reviewed by a licensed healthcare provider to determine whether an available weight-management treatment may be appropriate for their individual needs.

Physician-guided weight loss

See whether a GLP-1 treatment may be appropriate for you

New patient programs start from $99/month. Complete a brief online evaluation, and a licensed provider will review your history and determine whether treatment is appropriate.

Start your online visit

This article is for educational purposes only and is not a substitute for professional medical advice. Eligibility and treatment decisions are determined by a licensed healthcare provider. Prescription medications require medical evaluation and approval. Individual results vary.

This article is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Individual treatment decisions should be made with a licensed healthcare provider.

Sources & further reading

  1. Centers for Disease Control and Prevention. “About Body Mass Index (BMI).” Overview of BMI as a screening measure, its calculation, interpretation, and limitations when assessing individual health.
  2. Centers for Disease Control and Prevention. “Adult BMI Categories.” Reference for standard adult BMI classifications, including overweight and Classes 1, 2, and 3 obesity.
  3. Wegovy (semaglutide) Prescribing Information. Novo Nordisk. Reference for Wegovy's adult weight-management indications, patient selection, dosing, contraindications, and safety information.
  4. Zepbound (tirzepatide) Prescribing Information. Eli Lilly and Company. Reference for Zepbound's weight-management indications, patient selection, dosing, contraindications, and safety information.
  5. Wilding JPH, et al. (2022). “Weight Regain and Cardiometabolic Effects After Withdrawal of Semaglutide: The STEP 1 Trial Extension.” Diabetes, Obesity and Metabolism. Follow-up research examining changes in body weight following withdrawal of semaglutide treatment.

Share this article

Related articles

Luma

Mon-Friday 9am - 5:30 PM ET

Need help? Send us a message through your secure patient portal for the quickest response. You can also reach us by email. Most inquiries receive a reply within 24–48 business hours.

USA Pharmacies

Compounded medications have not been approved by the U.S. Food and Drug Administration (FDA). The FDA does not review compounded medications for safety, effectiveness, or quality before they are dispensed. These medications are prepared by licensed compounding pharmacies pursuant to a valid prescription for an individual patient.

Join Luma · HappyScale Wellness Corp.
271 Broadway #1005, Bethpage, NY 11714, United States
support@lumameds.com

Medical services provided by: Arora Health and Aesthetics (www.arora-health.com), led by CEO Dr. Sean Arora

Join Luma, operated by HappyScale Wellness Corp., provides a technology platform that connects patients with independent, state-licensed healthcare providers. Medical services available through the Join Luma platform, including patient evaluations, treatment decisions, and prescriptions, are provided by Arora Health and Aesthetics, led by CEO Dr. Sean Arora, the medical practice seeing patients, and/or other independent licensed healthcare providers affiliated with it, as applicable. HappyScale Wellness Corp. is not a medical practice or pharmacy and does not practice medicine, make medical treatment decisions, prescribe medications, or dispense prescription drugs.

All medical evaluations, treatment decisions, and prescriptions are made by appropriately licensed healthcare providers exercising their independent clinical judgment. When clinically appropriate, prescriptions may be fulfilled by independent, state-licensed 503A compounding pharmacies or FDA-registered 503B outsourcing facilities, as applicable.

Individual results vary. No specific outcome or amount of weight loss can be guaranteed. Treatment results depend on individual factors, including the patient's medical circumstances, adherence to the prescribed treatment plan, and lifestyle modifications.

© 2026 HappyScale Wellness Corp. All rights reserved.